Currently approved and emerging oral therapies in multiple sclerosis: An update for the ophthalmologist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Currently approved and emerging oral therapies in multiple sclerosis: An update for the ophthalmologist

Published:2016-05 Issue:3 Volume:61 Page:318-332
ISSN:0039-6257
Container-title:Survey of Ophthalmology
language:en
Short-container-title:Survey of Ophthalmology

Author:

Eckstein Christopher^ORCID,Bhatti M. Tariq

Publisher

Elsevier BV

Subject

Ophthalmology

Reference114 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group;Neurology,1993

2. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group;Neurology,1996

3. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations;Abou Zeid;Neurologist,2008

4. Citalopram for post-stroke pathological crying;Andersen;Lancet,1993

5. Evolving management of optic neuritis and multiple sclerosis;Arnold;Am J Ophthalmol,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan;Brain Sciences;2021-11-29

2. Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases;Immunology;2020-10-06

3. A Journey to the Conformational Analysis of T-Cell Epitope Peptides Involved in Multiple Sclerosis;Brain Sciences;2020-06-08

4. Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System;Brain Sciences;2020-06-02

5. The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis;IUBMB Life;2019-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3